CY1110706T1 - Αντιβακτηριδιακα παραγωγα κινολινης - Google Patents
Αντιβακτηριδιακα παραγωγα κινολινηςInfo
- Publication number
- CY1110706T1 CY1110706T1 CY20101100708T CY101100708T CY1110706T1 CY 1110706 T1 CY1110706 T1 CY 1110706T1 CY 20101100708 T CY20101100708 T CY 20101100708T CY 101100708 T CY101100708 T CY 101100708T CY 1110706 T1 CY1110706 T1 CY 1110706T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compounds
- preparation
- pharmaceutically acceptable
- treatment
- kinolin
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000035143 Bacterial infection Diseases 0.000 abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 2
- 125000000815 N-oxide group Chemical group 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 abstract 1
- -1 compound ions Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06125521 | 2006-12-06 | ||
| EP07847813A EP2086941B1 (en) | 2006-12-06 | 2007-12-04 | Antibacterial quinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110706T1 true CY1110706T1 (el) | 2015-06-10 |
Family
ID=37944337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20101100708T CY1110706T1 (el) | 2006-12-06 | 2010-07-28 | Αντιβακτηριδιακα παραγωγα κινολινης |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7998979B2 (OSRAM) |
| EP (1) | EP2086941B1 (OSRAM) |
| JP (1) | JP5356245B2 (OSRAM) |
| KR (1) | KR101490221B1 (OSRAM) |
| CN (1) | CN101541752B (OSRAM) |
| AR (1) | AR064150A1 (OSRAM) |
| AT (1) | ATE465994T1 (OSRAM) |
| AU (1) | AU2007328889B2 (OSRAM) |
| BR (1) | BRPI0720251B8 (OSRAM) |
| CA (1) | CA2668520C (OSRAM) |
| CL (1) | CL2007003516A1 (OSRAM) |
| CY (1) | CY1110706T1 (OSRAM) |
| DE (1) | DE602007006231D1 (OSRAM) |
| DK (1) | DK2086941T3 (OSRAM) |
| ES (1) | ES2344535T3 (OSRAM) |
| HR (1) | HRP20100384T1 (OSRAM) |
| IL (1) | IL199081A (OSRAM) |
| JO (1) | JO2685B1 (OSRAM) |
| ME (1) | ME01073B (OSRAM) |
| MX (1) | MX2009005980A (OSRAM) |
| NO (1) | NO341995B1 (OSRAM) |
| NZ (1) | NZ576673A (OSRAM) |
| PL (1) | PL2086941T3 (OSRAM) |
| PT (1) | PT2086941E (OSRAM) |
| RS (1) | RS51390B (OSRAM) |
| RU (1) | RU2446159C2 (OSRAM) |
| SI (1) | SI2086941T1 (OSRAM) |
| TW (1) | TWI412364B (OSRAM) |
| WO (1) | WO2008068269A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9133167B2 (en) | 2012-04-27 | 2015-09-15 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| KR102110366B1 (ko) | 2012-04-27 | 2020-05-14 | 얀센 파마슈티카 엔.브이. | 항균성 퀴놀린 유도체 |
| CN104650054B (zh) * | 2013-11-25 | 2019-09-13 | 重庆医药工业研究院有限责任公司 | 一种抗结核菌的喹啉噻吩芳氧乙胺衍生物 |
| US11857352B2 (en) | 2016-09-06 | 2024-01-02 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
| KR20240161147A (ko) | 2022-03-14 | 2024-11-12 | 슬랩 파마슈티컬스 엘엘씨 | 다중 사이클릭 화합물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6033389B2 (ja) * | 1979-02-22 | 1985-08-02 | 日産化学工業株式会社 | 複素環エ−テル系フェノシキ脂肪酸誘導体、その製造法および該誘導体を含有する除草剤 |
| US5965572A (en) | 1996-10-28 | 1999-10-12 | The United States Of America As Respresented By The Secretary Of The Army | Methods for treating antibiotic-resistant infections |
| EA007205B1 (ru) * | 2001-07-31 | 2006-08-25 | Вейне Стейт Юниверсити | Производные хинолина и их использование в качестве противоопухолевых средств |
| PT1527050E (pt) * | 2002-07-25 | 2010-06-22 | Janssen Pharmaceutica Nv | Derivados de quinolina e sua utilização como inibidores de micobactérias |
| KR101150172B1 (ko) | 2004-01-23 | 2012-05-25 | 얀센 파마슈티카 엔.브이. | 치환된 퀴놀린 및 마이코박테리아 저해제로서의 용도 |
| ATE444068T1 (de) * | 2004-01-23 | 2009-10-15 | Janssen Pharmaceutica Nv | Chinolinderivate und ihre verwendung als mycobakterielle inhibitoren |
| MXPA06008596A (es) * | 2004-01-29 | 2006-08-28 | Janssen Pharmaceutica Nv | Derivados de quinolina para uso como inhibidores micobacterianos. |
| JO2524B1 (en) * | 2004-05-28 | 2010-03-17 | جانسن فارمسيتكا ان في | Use of substituted quinoline derivatives to treat drug-resistant microbial diseases |
| KR101539021B1 (ko) | 2004-09-28 | 2015-07-23 | 얀센 파마슈티카 엔.브이. | 박테리아 ａｔｐ 합성효소 결합 부분 |
-
2007
- 2007-11-29 JO JO2007507A patent/JO2685B1/en active
- 2007-12-04 ME MEP-2010-111A patent/ME01073B/me unknown
- 2007-12-04 SI SI200730286T patent/SI2086941T1/sl unknown
- 2007-12-04 JP JP2009539740A patent/JP5356245B2/ja not_active Expired - Fee Related
- 2007-12-04 NZ NZ576673A patent/NZ576673A/en not_active IP Right Cessation
- 2007-12-04 CA CA2668520A patent/CA2668520C/en active Active
- 2007-12-04 AU AU2007328889A patent/AU2007328889B2/en not_active Ceased
- 2007-12-04 ES ES07847813T patent/ES2344535T3/es active Active
- 2007-12-04 PT PT07847813T patent/PT2086941E/pt unknown
- 2007-12-04 BR BRPI0720251A patent/BRPI0720251B8/pt not_active IP Right Cessation
- 2007-12-04 DK DK07847813.8T patent/DK2086941T3/da active
- 2007-12-04 CN CN2007800437666A patent/CN101541752B/zh not_active Expired - Fee Related
- 2007-12-04 KR KR1020097012572A patent/KR101490221B1/ko not_active Expired - Fee Related
- 2007-12-04 HR HR20100384T patent/HRP20100384T1/hr unknown
- 2007-12-04 EP EP07847813A patent/EP2086941B1/en active Active
- 2007-12-04 PL PL07847813T patent/PL2086941T3/pl unknown
- 2007-12-04 AT AT07847813T patent/ATE465994T1/de active
- 2007-12-04 RS RSP-2010/0340A patent/RS51390B/sr unknown
- 2007-12-04 US US12/516,370 patent/US7998979B2/en active Active
- 2007-12-04 WO PCT/EP2007/063315 patent/WO2008068269A1/en not_active Ceased
- 2007-12-04 MX MX2009005980A patent/MX2009005980A/es active IP Right Grant
- 2007-12-04 RU RU2009125525/04A patent/RU2446159C2/ru active
- 2007-12-04 DE DE602007006231T patent/DE602007006231D1/de active Active
- 2007-12-05 CL CL200703516A patent/CL2007003516A1/es unknown
- 2007-12-05 TW TW096146213A patent/TWI412364B/zh not_active IP Right Cessation
- 2007-12-05 AR ARP070105443A patent/AR064150A1/es unknown
-
2009
- 2009-06-02 IL IL199081A patent/IL199081A/en active IP Right Grant
- 2009-07-06 NO NO20092540A patent/NO341995B1/no unknown
-
2010
- 2010-07-28 CY CY20101100708T patent/CY1110706T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1117766T1 (el) | Αντιβακτηριδιακα παραγωγα κινολινης | |
| CY1111188T1 (el) | Αντιβακτηριακα παραγωγα κινολινης | |
| CY1110388T1 (el) | Χρηση υποκατεστημενων παραγωγων κουινολινης για τη θεραπευτικη αντιμετωπιση μυκοβακτηριακων ασθενειων ανθεκτικων σε φαρμακα | |
| CY1117247T1 (el) | Αντιβακτηριακα παραγωγα κινολινης | |
| CY1112230T1 (el) | Αντιβακτηριακα παραγωγα κινολινης | |
| MX2010007375A (es) | Nuevos derivados de lupano. | |
| EA201491982A1 (ru) | Антибактериальные хинолиновые производные | |
| CY1114384T1 (el) | Αντιβακτηριακα παραγωγα κινολινης | |
| CY1118515T1 (el) | Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες | |
| CY1112027T1 (el) | Αντιβακτηριακα παραγωγα κινολινης | |
| JO2685B1 (en) | Quinoline antibacterial derivatives | |
| EA201491971A1 (ru) | Антибактериальные хинолиновые производные | |
| GEAP201914711A (en) | New derivatives of adamantix benzimidazole as anthelmin- tic, antiviral and antibacterial agents |